| Year |
Citation |
Score |
| 2023 |
Pankhurst TE, Buick KH, Lange JL, Marshall AJ, Button KR, Palmer OR, Farrand KJ, Montgomerie I, Bird TW, Mason NC, Kuang J, Compton BJ, Comoletti D, Salio M, Cerundolo V, et al. MAIT cells activate dendritic cells to promote T cell differentiation and induce humoral immunity. Cell Reports. 42: 112310. PMID 36989114 DOI: 10.1016/j.celrep.2023.112310 |
0.333 |
|
| 2023 |
Kandasamy M, Gileadi U, Rijal P, Tan TK, Lee LN, Chen J, Prota G, Klenerman P, Townsend A, Cerundolo V. Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors. Elife. 12. PMID 36626205 DOI: 10.7554/eLife.76414 |
0.305 |
|
| 2021 |
Shenderov E, Kandasamy M, Gileadi U, Chen J, Shepherd D, Gibbs J, Prota G, Silk JD, Yewdell JW, Cerundolo V. Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1 tumor-specific peptide. Journal For Immunotherapy of Cancer. 9. PMID 34088742 DOI: 10.1136/jitc-2021-002544 |
0.355 |
|
| 2021 |
Crump NT, Hadjinicolaou AV, Xia M, Walsby-Tickle J, Gileadi U, Chen JL, Setshedi M, Olsen LR, Lau IJ, Godfrey L, Quek L, Yu Z, Ballabio E, Barnkob MB, Napolitani G, ... ... Cerundolo V, et al. Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation. Cell Reports. 35: 109101. PMID 33979616 DOI: 10.1016/j.celrep.2021.109101 |
0.353 |
|
| 2021 |
Yang H, Rei M, Brackenridge S, Brenna E, Sun H, Abdulhaqq S, Liu MKP, Ma W, Kurupati P, Xu X, Cerundolo V, Jenkins E, Davis SJ, Sacha JB, Früh K, et al. HLA-E-restricted, Gag-specific CD8 T cells can suppress HIV-1 infection, offering vaccine opportunities. Science Immunology. 6. PMID 33766848 DOI: 10.1126/sciimmunol.abg1703 |
0.608 |
|
| 2021 |
Dölen Y, Gileadi U, Chen JL, Valente M, Creemers JHA, Van Dinther EAW, van Riessen NK, Jäger E, Hruby M, Cerundolo V, Diken M, Figdor CG, de Vries IJM. PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses. Frontiers in Immunology. 12: 641703. PMID 33717196 DOI: 10.3389/fimmu.2021.641703 |
0.405 |
|
| 2020 |
Dölen Y, Valente M, Tagit O, Jäger E, Van Dinther EAW, van Riessen NK, Hruby M, Gileadi U, Cerundolo V, Figdor CG. Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses. Oncoimmunology. 9: 1738813. PMID 33457086 DOI: 10.1080/2162402X.2020.1738813 |
0.484 |
|
| 2020 |
Ioannidis M, Cerundolo V, Salio M. The Immune Modulating Properties of Mucosal-Associated Invariant T Cells. Frontiers in Immunology. 11: 1556. PMID 32903532 DOI: 10.3389/Fimmu.2020.01556 |
0.524 |
|
| 2020 |
Austin M, Burschowsky D, Chan DTY, Jenkinson L, Haynes S, Diamandakis A, Seewooruthun C, Addyman A, Fiedler S, Ryman S, Whitehouse J, Slater LH, Hadjinicolaou AV, Gileadi U, Gowans E, ... ... Cerundolo V, et al. Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action. Mabs. 12: 1801230. PMID 32880207 DOI: 10.1080/19420862.2020.1801230 |
0.337 |
|
| 2020 |
Salio M, Awad W, Veerapen N, Gonzalez-Lopez C, Kulicke C, Waithe D, Martens AWJ, Lewinsohn DM, Hobrath JV, Cox LR, Rossjohn J, Besra GS, Cerundolo V. Ligand-dependent downregulation of MR1 cell surface expression. Proceedings of the National Academy of Sciences of the United States of America. PMID 32341160 DOI: 10.1073/Pnas.2003136117 |
0.344 |
|
| 2020 |
Prota G, Gileadi U, Rei M, Lechuga-Vieco AV, Chen JL, Galiani S, Bedard M, Lau VWC, Fanchi LF, Artibani M, Hu Z, Gordon S, Rehwinkel J, Enríquez JA, Ahmed AA, ... ... Cerundolo V, et al. Enhanced immunogenicity of mitochondrial-localized proteins in cancer cells. Cancer Immunology Research. PMID 32205315 DOI: 10.1158/2326-6066.Cir-19-0467 |
0.42 |
|
| 2020 |
Hu Z, Artibani M, Alsaadi A, Wietek N, Morotti M, Shi T, Zhong Z, Santana Gonzalez L, El-Sahhar S, KaramiNejadRanjbar M, Mallett G, Feng Y, Masuda K, Zheng Y, Chong K, ... ... Cerundolo V, et al. The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells. Cancer Cell. 37: 226-242.e7. PMID 32049047 DOI: 10.1016/J.Ccell.2020.01.003 |
0.355 |
|
| 2020 |
Lange J, Anderson RJ, Marshall AJ, Chan ST, Bilbrough TS, Gasser O, Gonzalez-Lopez C, Salio M, Cerundolo V, Hermans IF, Painter GF. The chemical synthesis, stability and activity of MAIT cell prodrug agonists that access MR1 in recycling endosomes. Acs Chemical Biology. PMID 31909966 DOI: 10.1021/Acschembio.9B00902 |
0.428 |
|
| 2020 |
Chen YL, Gomes T, Hardman CS, Vieira Braga FA, Gutowska-Owsiak D, Salimi M, Gray N, Duncan DA, Reynolds G, Johnson D, Salio M, Cerundolo V, Barlow JL, McKenzie ANJ, Teichmann SA, et al. Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation. The Journal of Experimental Medicine. 217. PMID 31845972 DOI: 10.1084/Jem.20190811 |
0.334 |
|
| 2020 |
Salio M, Cerundolo V. Interactions Between MAIT Cells and Dendritic Cells. Methods in Molecular Biology (Clifton, N.J.). 2098: 125-139. PMID 31792819 DOI: 10.1007/978-1-0716-0207-2_8 |
0.462 |
|
| 2019 |
Abd Hamid M, Colin-York H, Khalid-Alham N, Browne M, Cerundolo L, Chen JL, Yao X, Rosendo-Machado S, Waugh C, Maldonado-Perez D, Bowes E, Verrill C, Cerundolo V, Conlon CP, Fritzsche M, et al. Self-maintaining CD103+ cancer-specific T cells are highly energetic with rapid cytotoxic and effector responses. Cancer Immunology Research. PMID 31771983 DOI: 10.1158/2326-6066.Cir-19-0554 |
0.413 |
|
| 2019 |
Li X, Wang R, Fan P, Yao X, Qin L, Peng Y, Ma M, Asley N, Chang X, Feng Y, Hu Y, Zhang Y, Li C, Fanning G, Jones S, ... ... Cerundolo V, et al. A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer. Frontiers in Oncology. 9: 1066. PMID 31709176 DOI: 10.3389/Fonc.2019.01066 |
0.445 |
|
| 2019 |
Bedard M, Shrestha D, Priestman DA, Wang Y, Schneider F, Matute JD, Iyer SS, Gileadi U, Prota G, Kandasamy M, Veerapen N, Besra G, Fritzsche M, Zeissig S, Shevchenko A, ... ... Cerundolo V, et al. Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 31690657 DOI: 10.1073/Pnas.1910097116 |
0.458 |
|
| 2019 |
Ogg G, Cerundolo V, McMichael AJ. Capturing the antigen landscape: HLA-E, CD1 and MR1. Current Opinion in Immunology. 59: 121-129. PMID 31445404 DOI: 10.1016/J.Coi.2019.07.006 |
0.428 |
|
| 2019 |
Abd Hamid M, Wang RZ, Yao X, Fan P, Li X, Chang XM, Feng Y, Jones S, Maldonado-Perez D, Waugh C, Verrill C, Simmons A, Cerundolo V, McMichael A, Conlon C, et al. Enriched HLA-E and CD94/NKG2A interaction limits antitumor CD8+ tumor-infiltrating T lymphocyte responses. Cancer Immunology Research. PMID 31213473 DOI: 10.1158/2326-6066.Cir-18-0885 |
0.41 |
|
| 2019 |
Corridoni D, Shiraishi S, Chapman T, Steevels T, Muraro D, Thézénas ML, Prota G, Chen JL, Gileadi U, Ternette N, Cerundolo V, Simmons A. NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-Presentation and CD8 T Cell Responses. Frontiers in Immunology. 10: 958. PMID 31114588 DOI: 10.3389/Fimmu.2019.00958 |
0.494 |
|
| 2019 |
Colin-York H, Javanmardi Y, Skamrahl M, Kumari S, Chang VT, Khuon S, Taylor A, Chew TL, Betzig E, Moeendarbary E, Cerundolo V, Eggeling C, Fritzsche M. Cytoskeletal Control of Antigen-Dependent T Cell Activation. Cell Reports. 26: 3369-3379.e5. PMID 30893608 DOI: 10.1016/J.Celrep.2019.02.074 |
0.488 |
|
| 2019 |
Napolitani G, Kurupati P, Teng KWW, Gibani MM, Rei M, Aulicino A, Preciado-Llanes L, Wong MT, Becht E, Howson L, de Haas P, Salio M, Blohmke CJ, Olsen LR, Pinto DMS, ... ... Cerundolo V, et al. Publisher Correction: Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses. Nature Immunology. PMID 30862955 DOI: 10.1038/S41590-019-0357-6 |
0.369 |
|
| 2019 |
Reinink P, Buter J, Mishra VK, Ishikawa E, Cheng TY, Willemsen PTJ, Porwollik S, Brennan PJ, Heinz E, Mayfield JA, Dougan G, van Els CA, Cerundolo V, Napolitani G, Yamasaki S, et al. Discovery of trehalose phospholipids reveals functional convergence with mycobacteria. The Journal of Experimental Medicine. PMID 30804000 DOI: 10.1084/Jem.20181812 |
0.305 |
|
| 2019 |
Michaels YS, Barnkob MB, Barbosa H, Baeumler TA, Thompson MK, Andre V, Colin-York H, Fritzsche M, Gileadi U, Sheppard HM, Knapp DJHF, Milne TA, Cerundolo V, Fulga TA. Precise tuning of gene expression levels in mammalian cells. Nature Communications. 10: 818. PMID 30778069 DOI: 10.1038/S41467-019-08777-Y |
0.359 |
|
| 2018 |
Haanen JB, Cerundolo V. NKG2A, a New Kid on the Immune Checkpoint Block. Cell. 175: 1720-1722. PMID 30550781 DOI: 10.1016/J.Cell.2018.11.048 |
0.466 |
|
| 2018 |
Napolitani G, Kurupati P, Teng KWW, Gibani MM, Rei M, Aulicino A, Preciado-Llanes L, Wong MT, Becht E, Howson L, de Haas P, Salio M, Blohmke CJ, Olsen LR, Pinto DMS, ... ... Cerundolo V, et al. Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses. Nature Immunology. PMID 29925993 DOI: 10.1038/S41590-018-0133-Z |
0.501 |
|
| 2018 |
Kenyon A, Gavriouchkina D, Zorman J, Chong-Morrison V, Napolitani G, Cerundolo V, Sauka-Spengler T. Generation of a double binary transgenic zebrafish model to study myeloid gene regulation in response to oncogene activation in melanocytes. Disease Models & Mechanisms. 11. PMID 29666124 DOI: 10.1242/Dmm.030056 |
0.4 |
|
| 2018 |
Howson LJ, Napolitani G, Shepherd D, Ghadbane H, Kurupati P, Preciado-Llanes L, Rei M, Dobinson HC, Gibani MM, Teng KWW, Newell EW, Veerapen N, Besra GS, Pollard AJ, Cerundolo V. MAIT cell clonal expansion and TCR repertoire shaping in human volunteers challenged with Salmonella Paratyphi A. Nature Communications. 9: 253. PMID 29343684 DOI: 10.1038/S41467-017-02540-X |
0.473 |
|
| 2017 |
Bedard M, Salio M, Cerundolo V. Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy. Frontiers in Immunology. 8: 1829. PMID 29326711 DOI: 10.3389/Fimmu.2017.01829 |
0.509 |
|
| 2017 |
Kurioka A, van Wilgenburg B, Javan RR, Hoyle R, van Tonder AJ, Harrold CL, Leng T, Howson LJ, Shepherd D, Cerundolo V, Brueggemann AB, Klenerman P. Diverse Streptococcus pneumoniae strains drive a MAIT cell response through MR1-dependent and cytokine-driven pathways. The Journal of Infectious Diseases. PMID 29267892 DOI: 10.1093/Infdis/Jix647 |
0.462 |
|
| 2017 |
Khatamzas E, Hipp MM, Gaughan D, Pichulik T, Leslie A, Fernandes RA, Muraro D, Booth S, Zausmer K, Sun MY, Kessler B, Rowland-Jones S, Cerundolo V, Simmons A. Snapin promotes HIV-1 transmission from dendritic cells by dampening TLR8 signaling. The Embo Journal. PMID 28923824 DOI: 10.15252/Embj.201695364 |
0.346 |
|
| 2017 |
Salio M, Gasser O, Gonzalez-Lopez C, Martens A, Veerapen N, Gileadi U, Verter JG, Napolitani G, Anderson R, Painter G, Besra GS, Hermans IF, Cerundolo V. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 28877992 DOI: 10.4049/Jimmunol.1700615 |
0.502 |
|
| 2017 |
Kenyon A, Gavriouchkina D, Zorman J, Napolitani G, Cerundolo V, Sauka-Spengler T. Active nuclear transcriptome analysis reveals inflammasome-dependent mechanism for early neutrophil response to Mycobacterium marinum. Scientific Reports. 7: 6505. PMID 28747644 DOI: 10.1038/S41598-017-06099-X |
0.31 |
|
| 2017 |
Johnson LA, Banerji S, Lawrance W, Gileadi U, Prota G, Holder KA, Roshorm YM, Hanke T, Cerundolo V, Gale NW, Jackson DG. Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1. Nature Immunology. PMID 28504698 DOI: 10.1038/Ni.3750 |
0.379 |
|
| 2017 |
Timosenko E, Hadjinicolaou AV, Cerundolo V. Modulation of cancer-specific immune responses by amino acid degrading enzymes. Immunotherapy. 9: 83-97. PMID 28000524 DOI: 10.2217/Imt-2016-0118 |
0.32 |
|
| 2017 |
Hadjinicolaou AV, Prota G, Scifo L, Timosenko E, Quek L, Nerlov C, Milne T, Vyas P, Cerundolo V. Analysis of arginine metabolism in acute myeloid leukaemia to provide insights into tumour immune escape strategies The Lancet. 389: 42-42. DOI: 10.1016/S0140-6736(17)30438-5 |
0.46 |
|
| 2016 |
Cheung KL, Jarrett R, Subramaniam S, Salimi M, Gutowska-Owsiak D, Chen YL, Hardman C, Xue L, Cerundolo V, Ogg G. Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a. The Journal of Experimental Medicine. PMID 27670592 DOI: 10.1084/Jem.20160258 |
0.517 |
|
| 2016 |
Timosenko E, Ghadbane H, Silk JD, Shepherd D, Gileadi U, Howson LJ, Laynes R, Zhao Q, Strausberg RL, Olsen LR, Taylor S, Buffa FM, Boyd R, Cerundolo V. Nutritional stress induced by tryptophan-degrading enzymes results in ATF4-dependent reprogramming of the amino acid transporter profile in tumor cells. Cancer Research. PMID 27651314 DOI: 10.1158/0008-5472.Can-15-3502 |
0.438 |
|
| 2016 |
Galson JD, Trück J, Clutterbuck EA, Fowler A, Cerundolo V, Pollard AJ, Lunter G, Kelly DF. Erratum to: B-cell repertoire dynamics after sequential hepatitis B vaccination and evidence for cross-reactive B-cell activation. Genome Medicine. 8: 81. PMID 27488676 DOI: 10.1186/S13073-016-0337-5 |
0.32 |
|
| 2016 |
Dölen Y, Kreutz M, Gileadi U, Tel J, Vasaturo A, van Dinther EA, van Hout-Kuijer MA, Cerundolo V, Figdor CG. Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses. Oncoimmunology. 5: e1068493. PMID 26942088 DOI: 10.1080/2162402X.2015.1068493 |
0.473 |
|
| 2016 |
Kamaladasa A, Wickramasinghe N, Adikari TN, Gomes L, Shyamali NLA, Salio M, Cerundolo V, Ogg GS, Malavige GN. Expansion of highly activated iNKT cells with altered phenotype in acute dengue infection Clinical and Experimental Immunology. 185: 228-38. PMID 26874822 DOI: 10.1111/Cei.12778 |
0.438 |
|
| 2016 |
Jukes JP, Gileadi U, Ghadbane H, Yu TF, Shepherd D, Cox LR, Besra GS, Cerundolo V. Non-glycosidic compounds can stimulate both human and mouse iNKT cells. European Journal of Immunology. PMID 26873393 DOI: 10.1002/Eji.201546114 |
0.46 |
|
| 2016 |
Jarrett R, Salio M, Lloyd-Lavery A, Subramaniam S, Bourgeois E, Archer C, Cheung KL, Hardman C, Chandler D, Salimi M, Gutowska-Owsiak D, Bernardino de la Serna J, Fallon PG, Jolin H, Mckenzie A, ... ... Cerundolo V, et al. Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase. Science Translational Medicine. 8: 325ra18. PMID 26865566 DOI: 10.1126/Scitranslmed.Aad6833 |
0.454 |
|
| 2016 |
Torreno-Pina JA, Manzo C, Salio M, Aichinger MC, Oddone A, Lakadamyali M, Shepherd D, Besra GS, Cerundolo V, Garcia-Parajo MF. The actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 26798067 DOI: 10.1073/Pnas.1514530113 |
0.476 |
|
| 2016 |
Nakaya HI, Clutterbuck E, Kazmin D, Wang L, Cortese M, Bosinger SE, Patel NB, Zak DE, Aderem A, Dong T, Del Giudice G, Rappuoli R, Cerundolo V, Pollard AJ, Pulendran B, et al. Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proceedings of the National Academy of Sciences of the United States of America. 113: 1853-8. PMID 26755593 DOI: 10.1073/Pnas.1519690113 |
0.326 |
|
| 2015 |
Galson JD, Trück J, Fowler A, Clutterbuck EA, Münz M, Cerundolo V, Reinhard C, van der Most R, Pollard AJ, Lunter G, Kelly DF. Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of Vaccine-specific Antibody Sequences. Ebiomedicine. 2: 2070-9. PMID 26844287 DOI: 10.1016/J.Ebiom.2015.11.034 |
0.326 |
|
| 2015 |
Van Rhijn I, van Berlo T, Hilmenyuk T, Cheng TY, Wolf BJ, Tatituri RV, Uldrich AP, Napolitani G, Cerundolo V, Altman JD, Willemsen P, Huang S, Rossjohn J, Besra GS, Brenner MB, et al. Human autoreactive T cells recognize CD1b and phospholipids. Proceedings of the National Academy of Sciences of the United States of America. PMID 26621732 DOI: 10.1073/Pnas.1520947112 |
0.505 |
|
| 2015 |
Galson JD, Trück J, Fowler A, Münz M, Cerundolo V, Pollard AJ, Lunter G, Kelly DF. In-Depth Assessment of Within-Individual and Inter-Individual Variation in the B Cell Receptor Repertoire. Frontiers in Immunology. 6: 531. PMID 26528292 DOI: 10.3389/Fimmu.2015.00531 |
0.349 |
|
| 2015 |
Subramaniam S, Aslam A, Misbah SA, Salio M, Cerundolo V, Moody DB, Ogg G. Elevated and cross-responsive CD1a-reactive T cells in bee and wasp venom allergic individuals. European Journal of Immunology. PMID 26518614 DOI: 10.1002/Eji.201545869 |
0.508 |
|
| 2015 |
Salio M, Cerundolo V. Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials. Frontiers in Immunology. 6: 388. PMID 26284072 DOI: 10.3389/Fimmu.2015.00388 |
0.538 |
|
| 2015 |
Howson LJ, Salio M, Cerundolo V. MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases. Frontiers in Immunology. 6: 303. PMID 26136743 DOI: 10.3389/Fimmu.2015.00303 |
0.418 |
|
| 2015 |
Galson JD, Clutterbuck EA, Trück J, Ramasamy MN, Münz M, Fowler A, Cerundolo V, Pollard AJ, Lunter G, Kelly DF. BCR repertoire sequencing: different patterns of B-cell activation after two Meningococcal vaccines. Immunology and Cell Biology. PMID 25976772 DOI: 10.1038/Icb.2015.57 |
0.371 |
|
| 2015 |
McEwen-Smith RM, Salio M, Cerundolo V. The regulatory role of invariant NKT cells in tumor immunity. Cancer Immunology Research. 3: 425-35. PMID 25941354 DOI: 10.1158/2326-6066.Cir-15-0062 |
0.445 |
|
| 2015 |
Hipp MM, Shepherd D, Booth S, Waithe D, Reis e Sousa C, Cerundolo V. The Processed Amino-Terminal Fragment of Human TLR7 Acts as a Chaperone To Direct Human TLR7 into Endosomes. Journal of Immunology (Baltimore, Md. : 1950). 194: 5417-25. PMID 25917086 DOI: 10.4049/Jimmunol.1402703 |
0.315 |
|
| 2015 |
McEwen-Smith RM, Salio M, Cerundolo V. CD1d-dependent endogenous and exogenous lipid antigen presentation. Current Opinion in Immunology. 34: 116-25. PMID 25805574 DOI: 10.1016/J.Coi.2015.03.004 |
0.501 |
|
| 2015 |
Brodovitch A, Shenderov E, Cerundolo V, Bongrand P, Pierres A, van der Merwe PA. T lymphocytes need less than 3 min to discriminate between peptide MHCs with similar TCR-binding parameters. European Journal of Immunology. 45: 1635-42. PMID 25782169 DOI: 10.1002/Eji.201445214 |
0.438 |
|
| 2015 |
Salio M, Cerundolo V. NKT-dependent B-cell activation in Gaucher disease. Blood. 125: 1200-2. PMID 25700422 DOI: 10.1182/Blood-2014-12-617514 |
0.399 |
|
| 2015 |
Bourgeois EA, Subramaniam S, Cheng TY, De Jong A, Layre E, Ly D, Salimi M, Legaspi A, Modlin RL, Salio M, Cerundolo V, Moody DB, Ogg G. Bee venom processes human skin lipids for presentation by CD1a. The Journal of Experimental Medicine. 212: 149-63. PMID 25584012 DOI: 10.1084/Jem.20141505 |
0.459 |
|
| 2015 |
Chen JL, Dawoodji A, Tarlton A, Gnjatic S, Tajar A, Karydis I, Browning J, Pratap S, Verfaille C, Venhaus RR, Pan L, Altman DG, Cebon JS, Old LL, Nathan P, ... ... Cerundolo V, et al. NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus. International Journal of Cancer. Journal International Du Cancer. 136: E590-601. PMID 25081390 DOI: 10.1002/Ijc.29118 |
0.468 |
|
| 2014 |
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, ... ... Cerundolo V, et al. Classification of current anticancer immunotherapies. Oncotarget. 5: 12472-508. PMID 25537519 DOI: 10.18632/Oncotarget.2998 |
0.343 |
|
| 2014 |
Salio M, Puleston DJ, Mathan TS, Shepherd D, Stranks AJ, Adamopoulou E, Veerapen N, Besra GS, Hollander GA, Simon AK, Cerundolo V. Essential role for autophagy during invariant NKT cell development. Proceedings of the National Academy of Sciences of the United States of America. 111: E5678-87. PMID 25512546 DOI: 10.1073/Pnas.1413935112 |
0.494 |
|
| 2014 |
Puleston DJ, Zhang H, Powell TJ, Lipina E, Sims S, Panse I, Watson AS, Cerundolo V, Townsend AR, Klenerman P, Simon AK. Autophagy is a critical regulator of memory CD8(+) T cell formation. Elife. 3. PMID 25385531 DOI: 10.7554/Elife.03706 |
0.424 |
|
| 2014 |
Dawoodji A, Chen JL, Shepherd D, Dalin F, Tarlton A, Alimohammadi M, Penna-Martinez M, Meyer G, Mitchell AL, Gan EH, Bratland E, Bensing S, Husebye ES, Pearce SH, Badenhoop K, ... ... Cerundolo V, et al. High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients. Journal of Immunology (Baltimore, Md. : 1950). 193: 2118-26. PMID 25063864 DOI: 10.4049/Jimmunol.1400056 |
0.461 |
|
| 2014 |
Salio M, Silk JD, Jones EY, Cerundolo V. Biology of CD1- and MR1-restricted T cells. Annual Review of Immunology. 32: 323-66. PMID 24499274 DOI: 10.1146/Annurev-Immunol-032713-120243 |
0.489 |
|
| 2014 |
Pan X, Huang LC, Dong T, Peng Y, Cerundolo V, McGowan S, Ogg G. Combinatorial HLA-peptide bead libraries for high throughput identification of CD8⺠T cell specificity. Journal of Immunological Methods. 403: 72-8. PMID 24309405 DOI: 10.1016/J.Jim.2013.11.023 |
0.493 |
|
| 2014 |
Puleston DJ, Zhang H, Powell TJ, Lipina E, Sims S, Panse I, Watson AS, Cerundolo V, Townsend AR, Klenerman P, Simon AK. Author response: Autophagy is a critical regulator of memory CD8+ T cell formation Elife. DOI: 10.7554/Elife.03706.017 |
0.384 |
|
| 2014 |
Galson JD, Clutterbuck EA, Trueck J, Muenz M, Fowler A, Cerundolo V, Pollard AJ, Lunter G, Kelly DF. Plasma cell antibody repertoire analysis following administration of meningococcal polysaccharide and protein-polysaccharide conjugate vaccines: evidence of distinct patterns of B cell activation Immunology. 143: 62-62. DOI: 10.1111/Imm.12406 |
0.406 |
|
| 2014 |
Torreno-Pina JA, Aichinger M, Manzo C, Salio M, Cerundolo V, Garcia-Parajo MF. The Actin Cytoskeleton Controls the Activation of Invariant Natural Killer T Cells by Fine-Tuning CD1d Nanoscale Aggregation on Antigen Presenting Cells Biophysical Journal. 106. DOI: 10.1016/J.Bpj.2013.11.1394 |
0.493 |
|
| 2013 |
Salio M, Ghadbane H, Shepherd D, Cypen J, Gileadi U, Aichinger MC, Napolitani G, Cerundolo V, Dushek O, Van Der Merwe PA, Qi X, Cox LR, Wojno J, Veerapen N, Besra GS, et al. Saposins modulate human invariant natural killer t cells self-Reactivity and facilitate lipid exchange with cd1d molecules during antigen presentation Proceedings of the National Academy of Sciences of the United States of America. 110: E4753-E4761. PMID 24248359 DOI: 10.1073/Pnas.1310050110 |
0.401 |
|
| 2013 |
Hipp MM, Shepherd D, Gileadi U, Aichinger MC, Kessler BM, Edelmann MJ, Essalmani R, Seidah NG, Reis e Sousa C, Cerundolo V. Processing of human toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes. Immunity. 39: 711-21. PMID 24138882 DOI: 10.1016/J.Immuni.2013.09.004 |
0.305 |
|
| 2013 |
Crawford G, Enders A, Gileadi U, Stankovic S, Zhang Q, Lambe T, Crockford TL, Lockstone HE, Freeman A, Arkwright PD, Smart JM, Ma CS, Tangye SG, Goodnow CC, Cerundolo V, et al. DOCK8 is critical for the survival and function of NKT cells. Blood. 122: 2052-61. PMID 23929855 DOI: 10.1182/Blood-2013-02-482331 |
0.474 |
|
| 2013 |
Mussai F, De Santo C, Abu-Dayyeh I, Booth S, Quek L, McEwen-Smith RM, Qureshi A, Dazzi F, Vyas P, Cerundolo V. Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment. Blood. 122: 749-58. PMID 23733335 DOI: 10.1182/Blood-2013-01-480129 |
0.37 |
|
| 2013 |
Shenderov K, Barber DL, Mayer-Barber KD, Gurcha SS, Jankovic D, Feng CG, Oland S, Hieny S, Caspar P, Yamasaki S, Lin X, Ting JP, Trinchieri G, Besra GS, Cerundolo V, et al. Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity of mycobacteria through mincle/CARD9 signaling and the inflammasome. Journal of Immunology (Baltimore, Md. : 1950). 190: 5722-30. PMID 23630357 DOI: 10.4049/Jimmunol.1203343 |
0.363 |
|
| 2013 |
Jervis PJ, Polzella P, Wojno J, Jukes JP, Ghadbane H, Garcia Diaz YR, Besra GS, Cerundolo V, Cox LR. Design, synthesis, and functional activity of labeled CD1d glycolipid agonists. Bioconjugate Chemistry. 24: 586-94. PMID 23458425 DOI: 10.1021/Bc300556E |
0.357 |
|
| 2013 |
Stock A, Napolitani G, Cerundolo V. Intestinal DC in migrational imprinting of immune cells. Immunology and Cell Biology. 91: 240-9. PMID 23295361 DOI: 10.1038/Icb.2012.73 |
0.436 |
|
| 2013 |
Salio M, Cerundolo V. Harnessing CD1d‐restricted iNKT cells to design novel vaccination strategies Isbt Science Series. 8: 157-160. DOI: 10.1111/Voxs.12034 |
0.51 |
|
| 2012 |
Davis LC, Morgan AJ, Chen JL, Snead CM, Bloor-Young D, Shenderov E, Stanton-Humphreys MN, Conway SJ, Churchill GC, Parrington J, Cerundolo V, Galione A. NAADP activates two-pore channels on T cell cytolytic granules to stimulate exocytosis and killing. Current Biology : Cb. 22: 2331-7. PMID 23177477 DOI: 10.1016/J.Cub.2012.10.035 |
0.36 |
|
| 2012 |
Porubsky S, Speak AO, Salio M, Jennemann R, Bonrouhi M, Zafarulla R, Singh Y, Dyson J, Luckow B, Lehuen A, Malle E, Müthing J, Platt FM, Cerundolo V, Gröne HJ. Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 189: 3007-17. PMID 22875802 DOI: 10.4049/Jimmunol.1201483 |
0.413 |
|
| 2012 |
Mussai F, De Santo C, Cerundolo V. Interaction between invariant NKT cells and myeloid-derived suppressor cells in cancer patients: evidence and therapeutic opportunities. Journal of Immunotherapy (Hagerstown, Md. : 1997). 35: 449-59. PMID 22735803 DOI: 10.1097/Cji.0B013E31825Be926 |
0.434 |
|
| 2012 |
Speak AO, Platt N, Salio M, te Vruchte D, Smith DA, Shepherd D, Veerapen N, Besra GS, Yanjanin NM, Simmons L, Imrie J, Wraith JE, Lachmann RH, Hartung R, Runz H, ... ... Cerundolo V, et al. Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C. European Journal of Immunology. 42: 1886-92. PMID 22585405 DOI: 10.1002/Eji.201141821 |
0.484 |
|
| 2012 |
Barral P, Sánchez-Niño MD, van Rooijen N, Cerundolo V, Batista FD. The location of splenic NKT cells favours their rapid activation by blood-borne antigen. The Embo Journal. 31: 2378-90. PMID 22505026 DOI: 10.1038/Emboj.2012.87 |
0.476 |
|
| 2012 |
Robert P, Aleksic M, Dushek O, Cerundolo V, Bongrand P, Van Der Merwe PA. Kinetics and mechanics of two-dimensional interactions between T cell receptors and different activating ligands Biophysical Journal. 102: 248-257. PMID 22339861 DOI: 10.1016/J.Bpj.2011.11.4018 |
0.416 |
|
| 2012 |
Wojno J, Jukes JP, Ghadbane H, Shepherd D, Besra GS, Cerundolo V, Cox LR. Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production. Acs Chemical Biology. 7: 847-55. PMID 22324848 DOI: 10.1021/Cb2005017 |
0.443 |
|
| 2012 |
Chang PP, Barral P, Fitch J, Pratama A, Ma CS, Kallies A, Hogan JJ, Cerundolo V, Tangye SG, Bittman R, Nutt SL, Brink R, Godfrey DI, Batista FD, Vinuesa CG. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nature Immunology. 13: 35-43. PMID 22120117 DOI: 10.1038/Ni.2166 |
0.49 |
|
| 2012 |
Silk KM, Silk JD, Ichiryu N, Davies TJ, Nolan KF, Leishman AJ, Carpenter L, Watt SM, Cerundolo V, Fairchild PJ. Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells. Gene Therapy. 19: 1035-40. PMID 22071967 DOI: 10.1038/Gt.2011.177 |
0.403 |
|
| 2011 |
Huang S, Cheng TY, Young DC, Layre E, Madigan CA, Shires J, Cerundolo V, Altman JD, Moody DB. Discovery of deoxyceramides and diacylglycerols as CD1b scaffold lipids among diverse groove-blocking lipids of the human CD1 system. Proceedings of the National Academy of Sciences of the United States of America. 108: 19335-40. PMID 22087000 DOI: 10.1073/Pnas.1112969108 |
0.395 |
|
| 2011 |
Silk JD, Lakhal S, Laynes R, Vallius L, Karydis I, Marcea C, Boyd CA, Cerundolo V. IDO induces expression of a novel tryptophan transporter in mouse and human tumor cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 1617-25. PMID 21742973 DOI: 10.4049/Jimmunol.1000815 |
0.378 |
|
| 2011 |
Stinchcombe JC, Salio M, Cerundolo V, Pende D, Arico M, Griffiths GM. Centriole polarisation to the immunological synapse directs secretion from cytolytic cells of both the innate and adaptive immune systems. Bmc Biology. 9: 45. PMID 21711522 DOI: 10.1186/1741-7007-9-45 |
0.442 |
|
| 2011 |
Dushek O, Aleksic M, Wheeler RJ, Zhang H, Cordoba SP, Peng YC, Chen JL, Cerundolo V, Dong T, Coombs D, van der Merwe PA. Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation. Science Signaling. 4: ra39. PMID 21653229 DOI: 10.1126/Scisignal.2001430 |
0.474 |
|
| 2011 |
Bozna BL, Polzella P, Rankl C, Zhu R, Salio M, Shepherd D, Duman M, Cerundolo V, Hinterdorfer P. Binding strength and dynamics of invariant natural killer cell T cell receptor/CD1d-glycosphingolipid interaction on living cells by single molecule force spectroscopy. The Journal of Biological Chemistry. 286: 15973-9. PMID 21454514 DOI: 10.1074/Jbc.M110.192674 |
0.426 |
|
| 2011 |
Stock A, Booth S, Cerundolo V. Prostaglandin E2 suppresses the differentiation of retinoic acid-producing dendritic cells in mice and humans. The Journal of Experimental Medicine. 208: 761-73. PMID 21444662 DOI: 10.1084/Jem.20101967 |
0.397 |
|
| 2011 |
Hutchinson S, Sims S, O'Hara G, Silk J, Gileadi U, Cerundolo V, Klenerman P. A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus. Plos One. 6: e14646. PMID 21304910 DOI: 10.1371/Journal.Pone.0014646 |
0.491 |
|
| 2011 |
Kaur R, Chen J, Dawoodji A, Cerundolo V, Garcia-Diaz YR, Wojno J, Cox LR, Besra GS, Moghaddam B, Perrie Y. Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells. Journal of Pharmaceutical Sciences. 100: 2724-33. PMID 21283989 DOI: 10.1002/Jps.22500 |
0.464 |
|
| 2011 |
Pei B, Speak AO, Shepherd D, Butters T, Cerundolo V, Platt FM, Kronenberg M. Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids. Journal of Immunology (Baltimore, Md. : 1950). 186: 1348-60. PMID 21191069 DOI: 10.4049/Jimmunol.1001008 |
0.379 |
|
| 2010 |
De Santo C, Arscott R, Booth S, Karydis I, Jones M, Asher R, Salio M, Middleton M, Cerundolo V. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nature Immunology. 11: 1039-46. PMID 20890286 DOI: 10.1038/Ni.1942 |
0.347 |
|
| 2010 |
Wadle A, Mischo A, Strahl S, Nishikawa H, Held G, Neumann F, Wullner B, Fischer E, Kleber S, Karbach J, Jager E, Shiku H, Odunsi K, Shrikant PA, Knuth A, ... Cerundolo V, et al. NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses. Yeast (Chichester, England). 27: 919-31. PMID 20672253 DOI: 10.1002/Yea.1796 |
0.408 |
|
| 2010 |
Zeissig S, Dougan SK, Barral DC, Junker Y, Chen Z, Kaser A, Ho M, Mandel H, McIntyre A, Kennedy SM, Painter GF, Veerapen N, Besra GS, Cerundolo V, Yue S, et al. Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. The Journal of Clinical Investigation. 120: 2889-99. PMID 20592474 DOI: 10.1172/Jci42703 |
0.388 |
|
| 2010 |
Nika K, Soldani C, Salek M, Paster W, Gray A, Etzensperger R, Fugger L, Polzella P, Cerundolo V, Dushek O, Höfer T, Viola A, Acuto O. Constitutively active Lck kinase in T cells drives antigen receptor signal transduction. Immunity. 32: 766-77. PMID 20541955 DOI: 10.1016/J.Immuni.2010.05.011 |
0.45 |
|
| 2010 |
Poulin LF, Salio M, Griessinger E, Anjos-Afonso F, Craciun L, Chen JL, Keller AM, Joffre O, Zelenay S, Nye E, Le Moine A, Faure F, Donckier V, Sancho D, Cerundolo V, et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. The Journal of Experimental Medicine. 207: 1261-71. PMID 20479117 DOI: 10.1084/Jem.20092618 |
0.425 |
|
| 2010 |
Cerundolo V, Barral P, Batista FD. Synthetic iNKT cell-agonists as vaccine adjuvants--finding the balance Current Opinion in Immunology. 22: 417-424. PMID 20471232 DOI: 10.1016/J.Coi.2010.04.003 |
0.455 |
|
| 2010 |
Barral P, Polzella P, Bruckbauer A, Rooijen Nv, Besra GS, Cerundolo V, Batista FD. CD169+ macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes Nature Immunology. 11: 303-312. PMID 20228797 DOI: 10.1038/Ni.1853 |
0.493 |
|
| 2010 |
Cerundolo V, Kronenberg M. The role of invariant NKT cells at the interface of innate and adaptive immunity. Seminars in Immunology. 22: 59-60. PMID 20172739 DOI: 10.1016/J.Smim.2010.01.002 |
0.345 |
|
| 2010 |
Aleksic M, Dushek O, Zhang H, Shenderov E, Chen JL, Cerundolo V, Coombs D, van der Merwe PA. Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time. Immunity. 32: 163-74. PMID 20137987 DOI: 10.1016/J.Immuni.2009.11.013 |
0.466 |
|
| 2010 |
Salio M, Silk JD, Cerundolo V. Recent advances in processing and presentation of CD1 bound lipid antigens. Current Opinion in Immunology. 22: 81-8. PMID 20080041 DOI: 10.1016/J.Coi.2009.12.008 |
0.452 |
|
| 2010 |
Chen JL, Morgan AJ, Stewart-Jones G, Shepherd D, Bossi G, Wooldridge L, Hutchinson SL, Sewell AK, Griffiths GM, van der Merwe PA, Jones EY, Galione A, Cerundolo V. Ca2+ release from the endoplasmic reticulum of NY-ESO-1-specific T cells is modulated by the affinity of TCR and by the use of the CD8 coreceptor. Journal of Immunology (Baltimore, Md. : 1950). 184: 1829-39. PMID 20053942 DOI: 10.4049/Jimmunol.0902103 |
0.392 |
|
| 2010 |
Gnjatic S, Cao Y, Reichelt U, Yekebas EF, Nölker C, Marx AH, Erbersdobler A, Nishikawa H, Hildebrandt Y, Bartels K, Horn C, Stahl T, Gout I, Filonenko V, Ling KL, ... Cerundolo V, et al. NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer. International Journal of Cancer. Journal International Du Cancer. 127: 381-93. PMID 19937794 DOI: 10.1002/Ijc.25058 |
0.478 |
|
| 2009 |
Salio M, Cerundolo V. Linking Inflammation to Natural Killer T Cell Activation Plos Biology. 7. PMID 19859527 DOI: 10.1371/Journal.Pbio.1000226 |
0.44 |
|
| 2009 |
Ishizuka J, Grebe K, Shenderov E, Peters B, Chen Q, Peng Y, Wang L, Dong T, Pasquetto V, Oseroff C, Sidney J, Hickman H, Cerundolo V, Sette A, Bennink JR, et al. Quantitating T cell cross-reactivity for unrelated peptide antigens. Journal of Immunology (Baltimore, Md. : 1950). 183: 4337-45. PMID 19734234 DOI: 10.4049/Jimmunol.0901607 |
0.432 |
|
| 2009 |
Lawson VJ, Maurice D, Silk JD, Cerundolo V, Weston K. Aberrant selection and function of invariant NKT cells in the absence of AP-1 transcription factor Fra-2. Journal of Immunology (Baltimore, Md. : 1950). 183: 2575-84. PMID 19620306 DOI: 10.4049/Jimmunol.0803577 |
0.418 |
|
| 2009 |
Palmowski MJ, Parker M, Choudhuri K, Chiu C, Callan MFC, Merwe PAvd, Cerundolo V, Gould KG. A Single-Chain H-2Db Molecule Presenting an Influenza Virus Nucleoprotein Epitope Shows Enhanced Ability at Stimulating CD8+ T Cell Responses In Vivo Journal of Immunology. 182: 4565-4571. PMID 19342630 DOI: 10.4049/Jimmunol.0803893 |
0.477 |
|
| 2009 |
Stewart-Jones G, Wadle A, Hombach A, Shenderov E, Held G, Fischer E, Kleber S, Nuber N, Stenner-Liewen F, Bauer S, McMichael A, Knuth A, Abken H, Hombach AA, Cerundolo V, et al. Rational development of high-affinity T-cell receptor-like antibodies. Proceedings of the National Academy of Sciences of the United States of America. 106: 5784-8. PMID 19307587 DOI: 10.1073/Pnas.0901425106 |
0.422 |
|
| 2009 |
Reddy BG, Silk JD, Salio M, Balamurugan R, Shepherd D, Ritter G, Cerundolo V, Schmidt RR. Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants. Chemmedchem. 4: 171-5. PMID 19160440 DOI: 10.1002/Cmdc.200800354 |
0.394 |
|
| 2009 |
Cerundolo V, Silk JD, Masri SH, Salio M. Harnessing invariant NKT cells in vaccination strategies. Nature Reviews. Immunology. 9: 28-38. PMID 19079136 DOI: 10.1038/Nri2451 |
0.428 |
|
| 2009 |
Stock A, Cerundolo V. Analysis of frequency and phenotype of antigen-specific T cells. Methods in Molecular Biology (Clifton, N.J.). 514: 1-14. PMID 19048209 DOI: 10.1007/978-1-60327-527-9_1 |
0.507 |
|
| 2008 |
De Santo C, Salio M, Masri SH, Lee LYH, Dong T, Speak AO, Porubsky S, Booth S, Veerapen N, Besra GS, Gröne HJ, Platt FM, Zambon M, Cerundolo V. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans Journal of Clinical Investigation. 118: 4036-4048. PMID 19033672 DOI: 10.1172/Jci36264 |
0.42 |
|
| 2008 |
Porubsky S, Luckow B, Bonrouhi M, Speak A, Cerundolo V, Platt F, Gröne HJ. [Glycosphingolipids Gb3 and iGb3. In vivo roles in hemolytic-uremic syndrome and iNKT cell function]. Pathologe. 29: 297-302. PMID 18810447 DOI: 10.1007/S00292-008-1040-0 |
0.325 |
|
| 2008 |
Silk JD, Salio M, Brown J, Jones EY, Cerundolo V. Structural and functional aspects of lipid binding by CD1 molecules. Annual Review of Cell and Developmental Biology. 24: 369-95. PMID 18593354 DOI: 10.1146/Annurev.Cellbio.24.110707.175359 |
0.407 |
|
| 2008 |
Barral P, Eckl-Dorna J, Harwood N, Santo CD, Salio M, Illarionov P, Besra G, Cerundolo V, Batista F. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo Proceedings of the National Academy of Sciences of the United States of America. 105: 8345-8350. PMID 18550831 DOI: 10.1073/Pnas.0802968105 |
0.483 |
|
| 2008 |
Speak AO, Cerundolo V, Platt FM. CD1d presentation of glycolipids. Immunology and Cell Biology. 86: 588-597. PMID 18542099 DOI: 10.1038/Icb.2008.42 |
0.491 |
|
| 2008 |
Silk JD, Salio M, Reddy BG, Shepherd D, Gileadi U, Brown J, Masri SH, Polzella P, Ritter G, Besra GS, Jones EY, Schmidt RR, Cerundolo V. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 6452-6. PMID 18453560 DOI: 10.4049/Jimmunol.180.10.6452 |
0.468 |
|
| 2008 |
Thomas M, Boname JM, Field S, Nejentsev S, Salio M, Cerundolo V, Wills M, Lehner PJ. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 105: 1656-61. PMID 18230726 DOI: 10.1073/Pnas.0707883105 |
0.438 |
|
| 2008 |
Barnes E, Salio M, Cerundolo V, Francesco L, Pardoll D, Klenerman P, Cox A. Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus. Journal of Viral Hepatitis. 15: 219-228. PMID 18194173 DOI: 10.1111/J.1365-2893.2007.00934.X |
0.308 |
|
| 2008 |
Oelke M, Kurokawa T, Hentrich I, Behringer D, Cerundolo V, Lindemann A, Mackensen A. Functional Characterization of CD8+ Antigen-Specific Cytotoxic T Lymphocytes after Enrichment Based on Cytokine Secretion: Comparison with the MHC-Tetramer Technology: Characterization of Cytokine-Enriched Antigen-Specific T Cells Scandinavian Journal of Immunology. 52: 544-549. DOI: 10.1111/J.1365-3083.2000.00810.X |
0.49 |
|
| 2008 |
Held G, Wadle A, Dauth N, Stewart‐Jones G, Sturm C, Thiel M, Zwick C, Dieckmann D, Schuler G, Hoogenboom HR, Lévy F, Cerundolo V, Pfreundschuh M, Renner C. Correction: MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing European Journal of Immunology. 38: 1465-1466. DOI: 10.1002/Eji.200890017 |
0.324 |
|
| 2007 |
Koch M, Camp S, Collen T, Avila D, Salomonsen J, Wallny HJ, van Hateren A, Hunt L, Jacob JP, Johnston F, Marston DA, Shaw I, Dunbar PR, Cerundolo V, Jones EY, et al. Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding. Immunity. 27: 885-99. PMID 18083574 DOI: 10.1016/J.Immuni.2007.11.007 |
0.323 |
|
| 2007 |
Salio M, Speak AO, Shepherd D, Polzella P, Illarionov PA, Veerapen N, Besra GS, Platt FM, Cerundolo V. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proceedings of the National Academy of Sciences of the United States of America. 104: 20490-20495. PMID 18077358 DOI: 10.1073/Pnas.0710145104 |
0.517 |
|
| 2007 |
Lopes L, Dewannieux M, Gileadi U, Bailey R, Ikeda Y, Whittaker C, Collin MP, Cerundolo V, Tomihari M, Ariizumi K, Collins MK. Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses. Journal of Virology. 82: 86-95. PMID 17959670 DOI: 10.1128/Jvi.01289-07 |
0.513 |
|
| 2007 |
Matthews KE, Qin JS, Yang J, Hermans IF, Palmowski MJ, Cerundolo V, Ronchese F. Increasing the survival of dendritic cells in vivo does not replace the requirement for CD4+ T cell help during primary CD8+ T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 179: 5738-47. PMID 17947646 DOI: 10.4049/Jimmunol.179.9.5738 |
0.437 |
|
| 2007 |
Jones EY, Salio M, Cerundolo V. T cell receptors get back to basics. Nature Immunology. 8: 1033-1035. PMID 17878911 DOI: 10.1038/Ni1007-1033 |
0.434 |
|
| 2007 |
Stronge VS, Salio M, Jones EY, Cerundolo V. A closer look at CD1d molecules: new horizons in studying NKT cells. Trends in Immunology. 28: 455-462. PMID 17825624 DOI: 10.1016/J.It.2007.08.002 |
0.499 |
|
| 2007 |
Cerundolo V, Salio M. Harnessing NKT Cells for Therapeutic Applications Current Topics in Microbiology and Immunology. 314: 325-340. PMID 17593667 DOI: 10.1007/978-3-540-69511-0_13 |
0.457 |
|
| 2007 |
Held G, Wadle A, Dauth N, Stewart-Jones G, Sturm C, Thiel M, Zwick C, Dieckmann D, Schuler G, Hoogenboom HR, Lévy F, Cerundolo V, Pfreundschuh M, Renner C. MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing. European Journal of Immunology. 37: 2008-17. PMID 17559180 DOI: 10.1002/Eji.200636545 |
0.345 |
|
| 2007 |
McCarthy C, Shepherd D, Fleire S, Stronge VS, Koch M, Illarionov PA, Bossi G, Salio M, Denkberg G, Reddington F, Tarlton A, Reddy BG, Schmidt RR, Reiter Y, Griffiths GM, ... ... Cerundolo V, et al. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. The Journal of Experimental Medicine. 204: 1131-44. PMID 17485514 DOI: 10.1084/Jem.20062342 |
0.38 |
|
| 2007 |
Wooldridge L, Lissina A, Vernazza J, Gostick E, Laugel B, Hutchinson SL, Mirza F, Dunbar PR, Boulter JM, Glick M, Cerundolo V, van den Berg HA, Price DA, Sewell AK. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region. European Journal of Immunology. 37: 1323-33. PMID 17429845 DOI: 10.1002/Eji.200636765 |
0.503 |
|
| 2007 |
Ling KL, Pratap SE, Bates GJ, Singh B, Mortensen NJ, George BD, Warren BF, Piris J, Roncador G, Fox SB, Banham AH, Cerundolo V. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients Cancer Immunity : a Journal of the Academy of Cancer Immunology. 7: 7. PMID 17388261 |
0.315 |
|
| 2007 |
Speak AO, Salio M, Neville DC, Fontaine J, Priestman DA, Platt N, Heare T, Butters TD, Dwek RA, Trottein F, Exley MA, Cerundolo V, Platt FM. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proceedings of the National Academy of Sciences of the United States of America. 104: 5971-6. PMID 17372214 DOI: 10.1073/Pnas.0607285104 |
0.443 |
|
| 2007 |
Porubsky S, Speak AO, Luckow B, Cerundolo V, Platt FM, Gröne HJ. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proceedings of the National Academy of Sciences of the United States of America. 104: 5977-5982. PMID 17372206 DOI: 10.1073/Pnas.0611139104 |
0.43 |
|
| 2007 |
Ling K, Dulphy N, Bahl P, Salio M, Maskell K, Piris J, Warren BF, George BD, Mortensen NJ, Cerundolo V. Modulation of CD103 expression on human colon carcinoma-specific CTL. Journal of Immunology. 178: 2908-2915. PMID 17312135 DOI: 10.4049/Jimmunol.178.5.2908 |
0.41 |
|
| 2007 |
Hermans IF, Silk JD, Gileadi U, Masri SH, Shepherd D, Farrand KJ, Salio M, Cerundolo V. Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells. Journal of Immunology (Baltimore, Md. : 1950). 178: 2721-9. PMID 17312114 DOI: 10.4049/Jimmunol.178.5.2721 |
0.429 |
|
| 2007 |
Chiu C, Heaps AG, Cerundolo V, McMichael AJ, Bangham CR, Callan MFC. Early acquisition of cytolytic function and transcriptional changes in a primary CD8+ T-cell response in vivo Blood. 109: 1086-1094. PMID 16990607 DOI: 10.1182/Blood-2006-03-011643 |
0.477 |
|
| 2006 |
Gadola SD, Silk JD, Jeans A, Illarionov PA, Salio M, Besra GS, Dwek R, Butters TD, Platt FM, Cerundolo V. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. The Journal of Experimental Medicine. 203: 2293-303. PMID 16982810 DOI: 10.1084/Jem.20060921 |
0.459 |
|
| 2006 |
Cerundolo V. Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense Seminars in Immunology. 18: 330-336. PMID 16973375 DOI: 10.1016/J.Smim.2006.07.006 |
0.41 |
|
| 2006 |
Mosley AJ, Meekings KN, McCarthy C, Shepherd D, Cerundolo V, Mazitschek R, Tanaka Y, Taylor GP, Bangham CR. Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection. Blood. 108: 3801-7. PMID 16912225 DOI: 10.1182/Blood-2006-03-013235 |
0.4 |
|
| 2006 |
Palmowski MJ, Gileadi U, Salio M, Gallimore A, Millrain M, James E, Addey C, Scott D, Dyson J, Simpson E, Cerundolo V. Role of immunoproteasomes in cross-presentation. Journal of Immunology (Baltimore, Md. : 1950). 177: 983-90. PMID 16818754 DOI: 10.4049/Jimmunol.177.2.983 |
0.373 |
|
| 2006 |
Purbhoo MA, Sutton DH, Brewer JE, Mullings RE, Hill ME, Mahon TM, Karbach J, Jäger E, Cameron BJ, Lissin N, Vyas P, Chen JL, Cerundolo V, Jakobsen BK. Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors. Journal of Immunology (Baltimore, Md. : 1950). 176: 7308-16. PMID 16751374 DOI: 10.4049/Jimmunol.176.12.7308 |
0.461 |
|
| 2006 |
Lau YS, Sabokbar A, Giele H, Cerundolo V, Hofstetter W, Athanasou NA. Malignant melanoma and bone resorption British Journal of Cancer. 94: 1496-1503. PMID 16641914 DOI: 10.1038/Sj.Bjc.6603103 |
0.326 |
|
| 2006 |
Gadola SD, Koch M, Marles-Wright J, Lissin NM, Shepherd D, Matulis G, Harlos K, Villiger PM, Stuart DI, Jakobsen BK, Cerundolo V, Jones EY. Structure and binding kinetics of three different human CD1d–α-galactosylceramide–specific T cell receptors Journal of Experimental Medicine. 203: 699-710. PMID 16520393 DOI: 10.1084/Jem.20052369 |
0.383 |
|
| 2006 |
Zhang J, Raper A, Sugita N, Hingorani R, Salio M, Palmowski MJ, Cerundolo V, Crocker PR. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood. 107: 3600-3608. PMID 16397130 DOI: 10.1182/Blood-2005-09-3842 |
0.352 |
|
| 2006 |
Chen N, McCarthy C, Drakesmith H, Li D, Cerundolo V, McMichael AJ, Screaton GR, Xu XN. HIV-1 down-regulates the expression of CD1d via Nef European Journal of Immunology. 36: 278-286. PMID 16385629 DOI: 10.1002/Eji.200535487 |
0.455 |
|
| 2006 |
Kotsianidis I, Silk JD, Spanoudakis E, Patterson S, Almeida A, Schmidt RR, Tsatalas C, Bourikas G, Cerundolo V, Roberts IA, Karadimitris A. Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells. Blood. 107: 3138-44. PMID 16373666 DOI: 10.1182/Blood-2005-07-2804 |
0.489 |
|
| 2006 |
Smith CL, Mirza F, Pasquetto V, Tscharke DC, Palmowski MJ, Dunbar PR, Sette A, Harris AL, Cerundolo V. Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara. Journal of Immunology (Baltimore, Md. : 1950). 175: 8431-7. PMID 16339586 DOI: 10.4049/Jimmunol.175.12.8431 |
0.432 |
|
| 2006 |
Ait-Tahar K, Cerundolo V, Banham AH, Hatton C, Blanchard T, Kusec R, Becker M, Smith GL, Pulford K. B and CTL responses to the ALK protein in patients with ALK-positive ALCL. International Journal of Cancer. 118: 688-95. PMID 16114011 DOI: 10.1002/Ijc.21410 |
0.414 |
|
| 2005 |
Trautmann L, Rimbert M, Echasserieau K, Saulquin X, Neveu B, Dechanet J, Cerundolo V, Bonneville M. Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 175: 6123-32. PMID 16237109 DOI: 10.4049/Jimmunol.175.9.6123 |
0.477 |
|
| 2005 |
Pasquetto V, Bui HH, Giannino R, Mirza F, Sidney J, Oseroff C, Tscharke DC, Irvine K, Bennink JR, Peters B, Southwood S, Cerundolo V, Grey H, Yewdell JW, Sette A. HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products Journal of Immunology. 175: 5504-5515. PMID 16210659 DOI: 10.4049/Jimmunol.175.8.5504 |
0.379 |
|
| 2005 |
Patterson S, Kotsianidis I, Almeida A, Politou M, Rahemtulla A, Matthew B, Schmidt RR, Cerundolo V, Roberts IA, Karadimitris A. Human invariant NKT cells are required for effective in vitro alloresponses. Journal of Immunology (Baltimore, Md. : 1950). 175: 5087-94. PMID 16210612 DOI: 10.4049/Jimmunol.175.8.5087 |
0.49 |
|
| 2005 |
Milicic A, Price DA, Zimbwa P, Booth BL, Brown HL, Easterbrook PJ, Olsen K, Robinson N, Gileadi U, Sewell AK, Cerundolo V, Phillips RE. CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef. Journal of Immunology (Baltimore, Md. : 1950). 175: 4618-26. PMID 16177107 DOI: 10.4049/Jimmunol.175.7.4618 |
0.349 |
|
| 2005 |
Koch M, Stronge VS, Shepherd D, Gadola SD, Mathew B, Ritter G, Fersht AR, Besra GS, Schmidt RR, Jones EY, Cerundolo V. The crystal structure of human CD1d with and without α-galactosylceramide Nature Immunology. 6: 819-826. PMID 16007090 DOI: 10.1038/Ni1225 |
0.3 |
|
| 2005 |
Roncador G, Brown PJ, Maestre L, Hue S, Martínez-Torrecuadrada JL, Ling KL, Pratap S, Toms C, Fox BC, Cerundolo V, Powrie F, Banham AH. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level European Journal of Immunology. 35: 1681-1691. PMID 15902688 DOI: 10.1002/Eji.200526189 |
0.417 |
|
| 2005 |
Salio M, Cerundolo V. Viral immunity: cross-priming with the help of TLR3. Current Biology. 15. PMID 15886091 DOI: 10.1016/J.Cub.2005.04.025 |
0.355 |
|
| 2005 |
Chen JL, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, Choi EM, Held G, Dunbar PR, Esnouf RM, Sami M, Boulter JM, Rizkallah P, Renner C, Sewell A, van der Merwe PA, ... ... Cerundolo V, et al. Structural and kinetic basis for heightened immunogenicity of T cell vaccines. The Journal of Experimental Medicine. 201: 1243-55. PMID 15837811 DOI: 10.1084/Jem.20042323 |
0.393 |
|
| 2005 |
Manders PM, Hunter PJ, Telaranta AI, Carr JM, Marshall JL, Carrasco M, Murakami Y, Palmowski MJ, Cerundolo V, Kaech SM, Ahmed R, Fearon DT. BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 102: 7418-25. PMID 15833813 DOI: 10.1073/Pnas.0501585102 |
0.474 |
|
| 2005 |
Renneson J, Salio M, Mazouz N, Goldman M, Marchant A, Cerundolo V. Mature dendritic cells differentiated in the presence of interferon-beta and interleukin-3 prime functional antigen-specific CD8 T cells. Clinical and Experimental Immunology. 139: 468-475. PMID 15730392 DOI: 10.1111/J.1365-2249.2005.02700.X |
0.439 |
|
| 2005 |
Maczek C, Berger TG, Schuler-Thurner B, Schultz ES, Hamann A, Dunbar PR, Cerundolo V, Steinkasserer A, Schuler G. Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients. International Journal of Cancer. Journal International Du Cancer. 115: 450-5. PMID 15688371 DOI: 10.1002/Ijc.20901 |
0.508 |
|
| 2005 |
Smith CL, Dunbar PR, Mirza F, Palmowski MJ, Shepherd D, Gilbert SC, Coulie P, Schneider J, Hoffman E, Hawkins R, Harris AL, Cerundolo V. Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence. International Journal of Cancer. 113: 259-66. PMID 15386406 DOI: 10.1002/Ijc.20569 |
0.424 |
|
| 2005 |
Cerundolo V. The role of invariant NKT cells in enhancing antigen specific T and B cell responses Journal of Immunotherapy. 28: 629-629. DOI: 10.1097/01.Cji.0000191001.24611.96 |
0.502 |
|
| 2005 |
Chong TW, Salio M, Hermans IF, Harris AL, Cerundolo V. Analysis of renal cell cancer tumour antigen carbonic anhydrase 9 specific cytotoxic T lymphocytes from a healthy HLA-A2 donor The Journal of Urology. 173: 96-96. DOI: 10.1016/S0022-5347(18)34605-6 |
0.399 |
|
| 2004 |
Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, Salio M, Mathew B, Schmidt RR, Lunt SJ, Williams KJ, Stratford IJ, Harris AL, Cerundolo V. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. The Journal of Clinical Investigation. 114: 1800-11. PMID 15599405 DOI: 10.1172/Jci200422046 |
0.535 |
|
| 2004 |
Collins MK, Cerundolo V. Gene therapy meets vaccine development Trends in Biotechnology. 22: 623-626. PMID 15542151 DOI: 10.1016/J.Tibtech.2004.10.006 |
0.354 |
|
| 2004 |
Barnes E, Salio M, Cerundolo V, Medlin J, Murphy S, Dusheiko G, Klenerman P. Impact of Alpha Interferon and Ribavirin on the Function of Maturing Dendritic Cells Antimicrobial Agents and Chemotherapy. 48: 3382-3389. PMID 15328100 DOI: 10.1128/Aac.48.9.3382-3389.2004 |
0.333 |
|
| 2004 |
Smith DC, Salio M, Lord JM, Roberts LM, Cerundolo V. Lack of dendritic cell maturation by the plant toxin ricin. European Journal of Immunology. 34: 2149-57. PMID 15259012 DOI: 10.1002/Eji.200425157 |
0.355 |
|
| 2004 |
Markel G, Achdout H, Katz G, Ling KL, Salio M, Gruda R, Gazit R, Mizrahi S, Hanna J, Gonen-Gross T, Arnon TI, Lieberman N, Stren N, Nachmias B, Blumberg RS, ... ... Cerundolo V, et al. Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients European Journal of Immunology. 34: 2138-2148. PMID 15259011 DOI: 10.1002/Eji.200425021 |
0.35 |
|
| 2004 |
Salio M, Palmowski MJ, Atzberger A, Hermans IF, Cerundolo V. CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. The Journal of Experimental Medicine. 199: 567-79. PMID 14970182 DOI: 10.1084/Jem.20031059 |
0.489 |
|
| 2004 |
Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, Dong T, Chesney G, Waters A, Easterbrook P, Dunbar PR, Shepherd D, Cerundolo V, Emery V, Griffiths P, et al. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. Plos Biology. 2: E20. PMID 14966528 DOI: 10.1371/Journal.Pbio.0020020 |
0.424 |
|
| 2004 |
Hermans IF, Silk JD, Yang J, Palmowski MJ, Gileadi U, McCarthy C, Salio M, Ronchese F, Cerundolo V. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. Journal of Immunological Methods. 285: 25-40. PMID 14871532 DOI: 10.1016/J.Jim.2003.10.017 |
0.418 |
|
| 2004 |
Palmowski MJ, Lopes L, Ikeda Y, Salio M, Cerundolo V, Collins MK. Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response. Journal of Immunology (Baltimore, Md. : 1950). 172: 1582-7. PMID 14734738 DOI: 10.4049/Jimmunol.172.3.1582 |
0.435 |
|
| 2004 |
Cerundolo V, Hermans IF, Salio M. Dendritic cells: a journey from laboratory to clinic. Nature Immunology. 5: 7-10. PMID 14699398 DOI: 10.1038/Ni0104-7 |
0.315 |
|
| 2004 |
Markel G, Mussaffi H, Ling KL, Salio M, Gadola S, Steuer G, Blau H, Achdout H, de Miguel M, Gonen-Gross T, Hanna J, Arnon TI, Qimron U, Volovitz I, Eisenbach L, ... ... Cerundolo V, et al. The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood. 103: 1770-8. PMID 14604968 DOI: 10.1182/Blood-2003-06-2114 |
0.431 |
|
| 2003 |
Wooldridge L, Hutchinson SL, Choi EM, Lissina A, Jones E, Mirza F, Dunbar PR, Price DA, Cerundolo V, Sewell AK. Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface. Journal of Immunology (Baltimore, Md. : 1950). 171: 6650-60. PMID 14662868 DOI: 10.4049/Jimmunol.171.12.6650 |
0.374 |
|
| 2003 |
Faroudi M, Utzny C, Salio M, Cerundolo V, Guiraud M, Müller S, Valitutti S. Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: Manifestation of a dual activation threshold Proceedings of the National Academy of Sciences of the United States of America. 100: 14145-14150. PMID 14610278 DOI: 10.1073/Pnas.2334336100 |
0.428 |
|
| 2003 |
Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 171: 5140-7. PMID 14607913 DOI: 10.4049/Jimmunol.171.10.5140 |
0.511 |
|
| 2003 |
Choi EM, Chen JL, Wooldridge L, Salio M, Lissina A, Lissin N, Hermans IF, Silk JD, Mirza F, Palmowski MJ, Dunbar PR, Jakobsen BK, Sewell AK, Cerundolo V. High avidity antigen-specific CTL identified by CD8-independent tetramer staining. Journal of Immunology (Baltimore, Md. : 1950). 171: 5116-23. PMID 14607910 DOI: 10.4049/Jimmunol.171.10.5116 |
0.487 |
|
| 2003 |
Salio M, Dulphy N, Renneson J, Herbert M, McMichael A, Marchant A, Cerundolo V. Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells. International Immunology. 15: 1265-1273. PMID 13679395 DOI: 10.1093/Intimm/Dxg123 |
0.495 |
|
| 2003 |
Yang JQ, Singh AK, Wilson MT, Satoh M, Stanic AK, Park JJ, Hong S, Gadola SD, Mizutani A, Kakumanu SR, Reeves WH, Cerundolo V, Joyce S, Van Kaer L, Singh RR. Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. Journal of Immunology (Baltimore, Md. : 1950). 171: 2142-53. PMID 12902521 DOI: 10.4049/Jimmunol.171.4.2142 |
0.459 |
|
| 2003 |
Schultz H, Schinke S, Weiss J, Cerundolo V, Gross WL, Gadola S. BPI-ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections. Clinical and Experimental Immunology. 133: 252-9. PMID 12869032 DOI: 10.1046/J.1365-2249.2003.02197.X |
0.315 |
|
| 2003 |
Gadola SD, Karadimitris A, Zaccai NR, Salio M, Dulphy N, Shepherd D, Jones EY, Cerundolo V. Generation of CD1 tetramers as a tool to monitor glycolipid-specific T cells Philosophical Transactions of the Royal Society B. 358: 875-877. PMID 12803920 DOI: 10.1098/Rstb.2003.1267 |
0.4 |
|
| 2003 |
Marchant A, Appay V, Sande Mvd, Dulphy N, Liesnard C, Kidd M, Kaye S, Ojuola O, Gillespie GMA, Cuero ALV, Cerundolo V, Callan M, McAdam KPWJ, Rowland-Jones SL, Donner C, et al. Mature CD8+ T lymphocyte response to viral infection during fetal life Journal of Clinical Investigation. 111: 1747-1755. PMID 12782677 DOI: 10.1172/Jci17470 |
0.441 |
|
| 2003 |
Wańkowicz-Kalińska A, van den Wijngaard RM, Tigges BJ, Westerhof W, Ogg GS, Cerundolo V, Storkus WJ, Das PK. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Laboratory Investigation; a Journal of Technical Methods and Pathology. 83: 683-95. PMID 12746478 DOI: 10.1097/01.Lab.0000069521.42488.1B |
0.422 |
|
| 2003 |
Jones E, Price DA, Dahm-Vicker M, Cerundolo V, Klenerman P, Gallimore A. The influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cells. Immunology. 109: 68-75. PMID 12709019 DOI: 10.1046/J.1365-2567.2003.01636.X |
0.388 |
|
| 2003 |
Salio M, Cella M, Vermi W, Facchetti F, Palmowski MJ, Smith CL, Shepherd D, Colonna M, Cerundolo V. Plasmacytoid dendritic cells prime IFN‐γ‐secreting melanoma‐specific CD8 lymphocytes and are found in primary melanoma lesions European Journal of Immunology. 33: 1052-1062. PMID 12672071 DOI: 10.1002/Eji.200323676 |
0.524 |
|
| 2003 |
Lautscham G, Haigh T, Mayrhofer S, Taylor G, Croom-Carter D, Leese A, Gadola S, Cerundolo V, Rickinson A, Blake N. Identification of a TAP-Independent, Immunoproteasome-Dependent CD8+ T-Cell Epitope in Epstein-Barr Virus Latent Membrane Protein 2 Journal of Virology. 77: 2757-2761. PMID 12552018 DOI: 10.1128/Jvi.77.4.2757-2761.2003 |
0.436 |
|
| 2003 |
Lucas M, Gadola S, Meier U, Young NT, Harcourt G, Karadimitris A, Coumi N, Brown D, Dusheiko G, Cerundolo V, Klenerman P. Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection. Journal of Virology. 77: 2251-2257. PMID 12525661 DOI: 10.1128/Jvi.77.3.2251-2257.2003 |
0.355 |
|
| 2002 |
Jones E, Dahm-Vicker M, Simon AK, Green A, Powrie F, Cerundolo V, Gallimore A. Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immunity. 2: 1. PMID 12747746 |
0.317 |
|
| 2002 |
Palmowski M, Salio M, Dunbar RP, Cerundolo V. The use of HLA class I tetramers to design a vaccination strategy for melanoma patients. Immunological Reviews. 188: 155-163. PMID 12445289 DOI: 10.1034/J.1600-065X.2002.18814.X |
0.399 |
|
| 2002 |
Smith CL, Dulphy N, Salio M, Cerundolo V. Immunotherapy of colorectal cancer. British Medical Bulletin. 64: 181-200. PMID 12421733 DOI: 10.1093/Bmb/64.1.181 |
0.455 |
|
| 2002 |
Simon AK, Gallimore A, Jones E, Sawitzki B, Cerundolo V, Screaton GR. Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies Cancer Cell. 2: 315-322. PMID 12398895 DOI: 10.1016/S1535-6108(02)00151-4 |
0.405 |
|
| 2002 |
Smith DC, Gallimore A, Jones E, Roberts B, Lord JM, Deeks E, Cerundolo V, Roberts LM. Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation. Journal of Immunology (Baltimore, Md. : 1950). 169: 99-107. PMID 12077234 DOI: 10.4049/Jimmunol.169.1.99 |
0.384 |
|
| 2002 |
Gadola SD, Dulphy N, Salio M, Cerundolo V. Vα24-JαQ-Independent, CD1d-Restricted Recognition of α-Galactosylceramide by Human CD4+ and CD8αβ+ T Lymphocytes Journal of Immunology. 168: 5514-5520. PMID 12023346 DOI: 10.4049/Jimmunol.168.11.5514 |
0.494 |
|
| 2002 |
Klenerman P, Cerundolo V, Dunbar PR. Tracking T cells with tetramers: new tales from new tools. Nature Reviews Immunology. 2: 263-272. PMID 12001997 DOI: 10.1038/Nri777 |
0.458 |
|
| 2002 |
Palmowski MJ, Choi EM, Hermans IF, Gilbert SC, Chen JL, Gileadi U, Salio M, Van Pel A, Man S, Bonin E, Liljestrom P, Dunbar PR, Cerundolo V. Competition between CTL narrows the immune response induced by prime-boost vaccination protocols. Journal of Immunology (Baltimore, Md. : 1950). 168: 4391-8. PMID 11970981 DOI: 10.4049/Jimmunol.168.9.4391 |
0.348 |
|
| 2002 |
Sewell AK, Booth BL, Cerundolo V, Phillips RE, Price DA. Differential processing of HLA A2-restricted HIV type 1 cytotoxic T lymphocyte epitopes. Viral Immunology. 15: 193-6. PMID 11952141 DOI: 10.1089/088282402317340332 |
0.428 |
|
| 2002 |
Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, ... ... Cerundolo V, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nature Medicine. 8: 379-85. PMID 11927944 DOI: 10.1038/Nm0402-379 |
0.382 |
|
| 2002 |
Glick M, Price DA, Vuidepot AL, Andersen TB, Hutchinson SL, Laugel B, Sewell AK, Boulter JM, Dunbar PR, Cerundolo V, Oxenius A, Bell JI, Richards WG, Jakobsen BK. Novel CD8+ T cell antagonists based on beta 2-microglobulin. The Journal of Biological Chemistry. 277: 20840-6. PMID 11914379 DOI: 10.1074/Jbc.M201819200 |
0.434 |
|
| 2001 |
Hemelaar J, Bex F, Booth B, Cerundolo V, McMichael A, Daenke S. Human T-Cell Leukemia Virus Type 1 Tax Protein Binds to Assembled Nuclear Proteasomes and Enhances Their Proteolytic Activity Journal of Virology. 75: 11106-11115. PMID 11602750 DOI: 10.1128/Jvi.75.22.11106-11115.2001 |
0.433 |
|
| 2001 |
Smith C, Cerundolo V. Immunotherapy of melanoma Immunology. 104: 1-7. PMID 11576213 DOI: 10.1046/J.1365-2567.2001.01297.X |
0.413 |
|
| 2001 |
Kelleher AD, Booth BL, Sewell AK, Oxenius A, Cerundolo V, McMichael AJ, Phillips RE, Price DA. Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes. Aids Research and Human Retroviruses. 17: 1063-6. PMID 11485623 DOI: 10.1089/088922201300343744 |
0.416 |
|
| 2001 |
Salio M, Shepherd D, Dunbar PR, Palmowski M, Murphy K, Wu L, Cerundolo V. Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC. Journal of Immunology. 167: 1188-1197. PMID 11466333 DOI: 10.4049/Jimmunol.167.3.1188 |
0.427 |
|
| 2001 |
Propato A, Cutrona G, Francavilla V, Ulivi M, Schiaffella E, Landt O, Dunbar R, Cerundolo V, Ferrarini M, Barnaba V. Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nature Medicine. 7: 807-813. PMID 11433345 DOI: 10.1038/89930 |
0.492 |
|
| 2001 |
Xu XN, Purbhoo MA, Chen N, Mongkolsapaya J, Cox JH, Meier UC, Tafuro S, Rod Dunbar P, Sewell AK, Hourigan CS, Appay V, Cerundolo V, Burrows SR, McMichael AJ, Screaton GR. A novel approach to antigen-specific deletion of CTL with minimal cellular activation using α3 domain mutants of MHC class I/peptide complex Immunity. 14: 591-602. PMID 11371361 DOI: 10.1016/S1074-7613(01)00133-9 |
0.425 |
|
| 2001 |
Karadimitris A, Gadola S, Altamirano M, Brown D, Woolfson A, Klenerman P, Chen JL, Koezuka Y, Roberts IA, Price DA, Dusheiko G, Milstein C, Fersht A, Luzzatto L, Cerundolo V. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proceedings of the National Academy of Sciences of the United States of America. 98: 3294-8. PMID 11248072 DOI: 10.1073/Pnas.051604498 |
0.447 |
|
| 2000 |
Oelke M, Kurokawa T, Hentrich I, Behringer D, Cerundolo V, Lindemann A, Mackensen A. Functional characterization of CD8(+) antigen-specific cytotoxic T lymphocytes after enrichment based on cytokine secretion: comparison with the MHC-tetramer technology. Scandinavian Journal of Immunology. 52: 544-549. PMID 11119258 DOI: 10.1046/J.1365-3083.2000.00810.X |
0.526 |
|
| 2000 |
Dunbar PR, Smith CL, Chao D, Salio M, Shepherd D, Mirza F, Lipp M, Lanzavecchia A, Sallusto F, Evans A, Russell-Jones R, Harris AL, Cerundolo V. A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. Journal of Immunology (Baltimore, Md. : 1950). 165: 6644-52. PMID 11086110 DOI: 10.4049/Jimmunol.165.11.6644 |
0.414 |
|
| 2000 |
Gnjatic S, Nagata Y, Jager E, Stockert E, Shankara S, Roberts BL, Mazzara GP, Lee SY, Dunbar PR, Dupont B, Cerundolo V, Ritter G, Chen YT, Knuth A, Old LJ. Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proceedings of the National Academy of Sciences of the United States of America. 97: 10917-22. PMID 11005863 DOI: 10.1073/Pnas.97.20.10917 |
0.514 |
|
| 2000 |
Schuler-Thurner B, Dieckmann D, Keikavoussi P, Bender A, Maczek C, Jonuleit H, Röder C, Haendle I, Leisgang W, Dunbar R, Cerundolo V, Driesch PvD, Knop J, Bröcker EB, Enk A, et al. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. Journal of Immunology. 165: 3492-3496. PMID 10975870 DOI: 10.4049/Jimmunol.165.6.3492 |
0.453 |
|
| 2000 |
Cerundolo V. Use of major histocompatibility complex class I tetramers to monitor tumor-specific cytotoxic T lymphocyte response in melanoma patients. Cancer Chemotherapy and Pharmacology. 46. PMID 10950154 DOI: 10.1007/Pl00014056 |
0.434 |
|
| 2000 |
Gadola SD, Moins-Teisserenc HT, Trowsdale J, Gross WL, Cerundolo V. TAP deficiency syndrome Clinical and Experimental Immunology. 121: 173-178. PMID 10931128 DOI: 10.1046/J.1365-2249.2000.01264.X |
0.314 |
|
| 2000 |
Appay V, Dunbar PR, Cerundolo V, McMichael A, Czaplewski L, Rowland-Jones S. RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation International Immunology. 12: 1173-1182. PMID 10917892 DOI: 10.1093/Intimm/12.8.1173 |
0.48 |
|
| 2000 |
Larsson M, Messmer D, Somersan S, Fonteneau JF, Donahoe SM, Lee M, Dunbar PR, Cerundolo V, Julkunen I, Nixon DF, Bhardwaj N. Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 165: 1182-90. PMID 10903715 DOI: 10.4049/Jimmunol.165.3.1182 |
0.487 |
|
| 2000 |
Chen J, Dunbar PR, Gileadi U, Jäger E, Gnjatic S, Nagata Y, Stockert E, Panicali DL, Chen Y, Knuth A, Old LJ, Cerundolo V. Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL Journal of Immunology. 165: 948-955. PMID 10878370 DOI: 10.4049/Jimmunol.165.2.948 |
0.375 |
|
| 2000 |
Valmori D, Dutoit V, Liénard D, Lejeune F, Speiser D, Rimoldi D, Cerundolo V, Dietrich P, Cerottini J, Romero P. Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients. Journal of Immunology. 165: 533-538. PMID 10861093 DOI: 10.4049/Jimmunol.165.1.533 |
0.42 |
|
| 2000 |
Jäger E, Nagata Y, Gnjatic S, Wada H, Stockert E, Karbach J, Dunbar PR, Lee SY, Jungbluth A, Jäger D, Arand M, Ritter G, Cerundolo V, Dupont B, Chen YT, et al. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proceedings of the National Academy of Sciences of the United States of America. 97: 4760-5. PMID 10781081 DOI: 10.1073/Pnas.97.9.4760 |
0.504 |
|
| 2000 |
Mackensen A, Herbst B, Chen J, Köhler G, Noppen C, Herr W, Spagnoli GC, Cerundolo V, Lindemann A. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. International Journal of Cancer. 86: 385-392. PMID 10760827 DOI: 10.1002/(Sici)1097-0215(20000501)86:3<385::Aid-Ijc13>3.0.Co;2-T |
0.44 |
|
| 2000 |
Ogg GS, Dunbar PR, Cerundolo V, McMichael AJ, Lemoine NR, Savage P. Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes. British Journal of Cancer. 82: 1058-1062. PMID 10737389 DOI: 10.1054/Bjoc.1999.1042 |
0.425 |
|
| 2000 |
Salio M, Cerundolo V, Lanzavecchia A. Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells. European Journal of Immunology. 30: 705-708. PMID 10671230 DOI: 10.1002/1521-4141(200002)30:2<705::Aid-Immu705>3.0.Co;2-P |
0.419 |
|
| 2000 |
Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, Cerundolo V, Borysiewicz LK, McMichael AJ, Wilkinson GWG. Surface Expression of HLA-E, an Inhibitor of Natural Killer Cells, Enhanced by Human Cytomegalovirus gpUL40 Science. 287: 1031-1033. PMID 10669413 DOI: 10.1126/Science.287.5455.1031 |
0.368 |
|
| 2000 |
Valmori D, Lévy F, Miconnet I, Zajac P, Spagnoli GC, Rimoldi D, Liénard D, Cerundolo V, Cerottini JC, Romero P. Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue. Journal of Immunology (Baltimore, Md. : 1950). 164: 1125-31. PMID 10623865 DOI: 10.4049/Jimmunol.164.2.1125 |
0.347 |
|
| 1999 |
Valmori D, Fonteneau J, Valitutti S, Gervois N, Dunbar R, Liénard D, Rimoldi D, Cerundolo V, Jotereau F, Cerottini J, Speiser DE, Romero P. Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues International Immunology. 11: 1971-1980. PMID 10590263 DOI: 10.1093/Intimm/11.12.1971 |
0.512 |
|
| 1999 |
Moins-Teisserenc HT, Gadola SD, Cella M, Dunbar PR, Exley A, Blake N, Baycal C, Lambert J, Bigliardi P, Willemsen M, Jones M, Buechner S, Colonna M, Gross WL, Cerundolo V. Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules The Lancet. 354: 1598-1603. PMID 10560675 DOI: 10.1016/S0140-6736(99)04206-3 |
0.358 |
|
| 1999 |
Cerundolo V. Tumour immunology: T cells work together to fight cancer Current Biology. 9. PMID 10508600 DOI: 10.1016/S0960-9822(99)80442-4 |
0.45 |
|
| 1999 |
Speiser DE, Pittet MJ, Valmori D, Dunbar R, Rimoldi D, Liénard D, MacDonald HR, Cerottini JC, Cerundolo V, Romero P. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. Journal of Experimental Medicine. 190: 775-782. PMID 10499916 DOI: 10.1084/Jem.190.6.775 |
0.467 |
|
| 1999 |
Pittet MJ, Valmori D, Dunbar PR, Speiser DE, Liénard D, Lejeune F, Fleischhauer K, Cerundolo V, Cerottini J, Romero P. High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals Journal of Experimental Medicine. 190: 705-716. PMID 10477554 DOI: 10.1084/Jem.190.5.705 |
0.477 |
|
| 1999 |
Anichini A, Molla A, Mortarini R, Tragni G, Bersani I, Nicola MD, Gianni AM, Pilotti S, Dunbar R, Cerundolo V, Parmiani G. An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions Journal of Experimental Medicine. 190: 651-667. PMID 10477550 DOI: 10.1084/Jem.190.5.651 |
0.52 |
|
| 1999 |
Gileadi U, Gallimore A, Bruggen PVd, Cerundolo V. Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes. European Journal of Immunology. 29: 2213-2222. PMID 10427984 DOI: 10.1002/(Sici)1521-4141(199907)29:07<2213::Aid-Immu2213>3.0.Co;2-8 |
0.319 |
|
| 1999 |
Dhodapkar MV, Steinman RM, Sapp M, Desai H, Fossella C, Krasovsky J, Donahoe SM, Dunbar PR, Cerundolo V, Nixon DF, Bhardwaj N. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. The Journal of Clinical Investigation. 104: 173-80. PMID 10411546 DOI: 10.1172/Jci6909 |
0.482 |
|
| 1999 |
Noakes KL, Teisserenc HT, Lord JM, Dunbar PR, Cerundolo V, Roberts LM. Exploiting retrograde transport of Shiga‐like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway Febs Letters. 453: 95-99. PMID 10403383 DOI: 10.1016/S0014-5793(99)00609-2 |
0.434 |
|
| 1999 |
Speiser DE, Valmori D, Rimoldi D, Pittet MJ, Liénard D, Cerundolo V, MacDonald HR, Cerottini JC, Romero P. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. European Journal of Immunology. 29: 1990-1999. PMID 10382762 DOI: 10.1002/(Sici)1521-4141(199906)29:06<1990::Aid-Immu1990>3.0.Co;2-9 |
0.456 |
|
| 1999 |
Bachmann MF, Gallimore A, Linkert S, Cerundolo V, Lanzavecchia A, Kopf M, Viola A. Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells. Journal of Experimental Medicine. 189: 1521-1530. PMID 10330431 DOI: 10.1084/Jem.189.10.1521 |
0.475 |
|
| 1999 |
Valmori D, Gileadi U, Servis C, Dunbar PR, Cerottini JC, Romero P, Cerundolo V, Lévy F. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3. The Journal of Experimental Medicine. 189: 895-906. PMID 10075973 DOI: 10.1084/Jem.189.6.895 |
0.462 |
|
| 1998 |
Young NT, Mulder A, Cerundolo V, Claas FH, Welsh KI. Expression of HLA class I antigens in transporter associated with antigen processing (TAP)-deficient mutant cell lines. Tissue Antigens. 52: 368-73. PMID 9820600 DOI: 10.1111/J.1399-0039.1998.Tb03057.X |
0.424 |
|
| 1998 |
Romero P, Dunbar PR, Valmori D, Pittet M, Ogg GS, Rimoldi D, Chen J, Liénard D, Cerottini J, Cerundolo V. Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes Journal of Experimental Medicine. 188: 1641-1650. PMID 9802976 DOI: 10.1084/Jem.188.9.1641 |
0.4 |
|
| 1998 |
Young NT, Rust NA, Dallman MJ, Cerundolo V, Morris PJ, Welsh KI. Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells. Human Immunology. 59: 700-12. PMID 9796738 DOI: 10.1016/S0198-8859(98)00078-0 |
0.391 |
|
| 1998 |
André P, Groettrup M, Klenerman P, de Giuli R, Booth BL, Cerundolo V, Bonneville M, Jotereau F, Zinkernagel RM, Lotteau V. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proceedings of the National Academy of Sciences of the United States of America. 95: 13120-4. PMID 9789051 DOI: 10.1073/Pnas.95.22.13120 |
0.362 |
|
| 1998 |
Ogg GS, Dunbar PR, Romero P, Chen J, Cerundolo V. High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo Journal of Experimental Medicine. 188: 1203-1208. PMID 9743539 DOI: 10.1084/Jem.188.6.1203 |
0.445 |
|
| 1998 |
Dunbar PR, Ogg GS, Chen J, Rust N, Bruggen Pvd, Cerundolo V. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Current Biology. 8: 413-416. PMID 9545200 DOI: 10.1016/S0960-9822(98)70161-7 |
0.473 |
|
| 1998 |
Braud VM, McMichael AJ, Cerundolo V. Differential processing of influenza nucleoprotein in human and mouse cells. European Journal of Immunology. 28: 625-635. PMID 9521073 DOI: 10.1002/(Sici)1521-4141(199802)28:02<625::Aid-Immu625>3.0.Co;2-I |
0.415 |
|
| 1998 |
Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF, McMichael AJ. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA Science. 279: 2103-2106. PMID 9516110 DOI: 10.1126/Science.279.5359.2103 |
0.322 |
|
| 1998 |
Valmori, Dunbar DR, Rimoldi D, Liénard D, Cerottini JC, Cerundolo V, Romero P. Monitoring tumor antigen-specific cytolytic T lymphocytes with fluorescent tetramers in melanoma Biomedicine & Pharmacotherapy. 52: 342. DOI: 10.1016/S0753-3322(98)80116-9 |
0.398 |
|
| 1997 |
Teisserenc H, Schmitt W, Blake N, Dunbar R, Gadola S, Gross WL, Exley A, Cerundolo V. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway Immunology Letters. 57: 183-187. PMID 9232449 DOI: 10.1016/S0165-2478(97)00072-2 |
0.392 |
|
| 1997 |
Cerundolo V, Benham A, Braud V, Mukherjee S, Gould K, Macino B, Neefjes J, Townsend A. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells European Journal of Immunology. 27: 336-341. PMID 9022037 DOI: 10.1002/Eji.1830270148 |
0.442 |
|
| 1997 |
Braud V, Cerundolo V, McMichael A. Differential processing of an influenza nucleoprotein epitope in human and murine cells Immunology Letters. 56: 241. DOI: 10.1016/S0165-2478(97)85957-3 |
0.329 |
|
| 1995 |
Cerundolo V, Kelly A, Elliott T, Trowsdale J, Townsend A. Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. European Journal of Immunology. 25: 554-562. PMID 7875220 DOI: 10.1002/Eji.1830250238 |
0.396 |
|
| 1995 |
Elliott T, Willis A, Cerundolo V, Townsend A. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. Journal of Experimental Medicine. 181: 1481-1491. PMID 7699331 DOI: 10.1084/Jem.181.4.1481 |
0.37 |
|
| 1995 |
Tomiyama H, Takamiya Y, Hill AB, Cerundolo V, Kelly A, Egawa K, Trowsdale J, Takiguchi M. Isolation of a human allo-peptide presented by HLA-B51 molecules International Immunology. 7: 905-909. PMID 7577798 DOI: 10.1093/Intimm/7.6.905 |
0.404 |
|
| 1993 |
Cerundolo V. Antigen processing and presentation. The role of the endoplasmic reticulum. Sub-Cellular Biochemistry. 21: 209-228. PMID 8256268 DOI: 10.1007/978-1-4615-2912-5_10 |
0.468 |
|
| 1993 |
Elvin J, Potter C, Elliott T, Cerundolo V, Townsend A. A method to quantify binding of unlabeled peptides to class I MHC molecules and detect their allele specificity Journal of Immunological Methods. 158: 161-171. PMID 7679131 DOI: 10.1016/0022-1759(93)90210-X |
0.331 |
|
| 1992 |
Binnendijk RSv, Baalen CAv, Poelen MC, Vries Pd, Boes J, Cerundolo V, Osterhaus AD, UytdeHaag FG. Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition. Journal of Experimental Medicine. 176: 119-128. PMID 1613454 DOI: 10.1084/Jem.176.1.119 |
0.36 |
|
| 1992 |
Zanovello P, Rosato A, Bronte V, Mandruzzato S, Cerundolo V, Collavo D. Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases. Cancer Immunology, Immunotherapy : Cii. 35: 27-32. PMID 1611620 DOI: 10.1007/Bf01741051 |
0.738 |
|
| 1992 |
Spies T, Cerundolo V, Colonna M, Cresswell P, Townsend A, DeMars R. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature. 355: 644-6. PMID 1538752 DOI: 10.1038/355644A0 |
0.373 |
|
| 1992 |
Cerundolo V, Elliott T, Elvin J, Bastin J, Townsend A. Association of the human invariant chain with H-2 Db class I molecules. European Journal of Immunology. 22: 2243-8. PMID 1516617 DOI: 10.1002/Eji.1830220910 |
0.332 |
|
| 1992 |
Elliott T, Cerundolo V, Townsend A. Short peptides assist the folding of free class I heavy chains in solution. European Journal of Immunology. 22: 3121-3125. PMID 1280223 DOI: 10.1002/Eji.1830221214 |
0.367 |
|
| 1991 |
Elliott T, Cerundolo V, Elvin J, Townsend A. Peptide-induced conformational change of the class I heavy chain Nature. 351: 402-406. PMID 2034289 DOI: 10.1038/351402A0 |
0.317 |
|
| 1991 |
Elvin J, Cerundolo V, Elliott T, Townsend A. A quantitative assay of peptide-dependent class I assembly. European Journal of Immunology. 21: 2025-2031. PMID 1909640 DOI: 10.1002/Eji.1830210909 |
0.304 |
|
| 1991 |
Cerundolo V, Elliott T, Elvin J, Bastin J, Rammensee HG, Townsend A. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. European Journal of Immunology. 21: 2069-75. PMID 1889458 DOI: 10.1002/Eji.1830210915 |
0.313 |
|
| 1991 |
Cerundolo V, Tse AG, Salter RD, Parham P, Townsend A. CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68.1. Proceedings. Biological Sciences / the Royal Society. 244: 169-77. PMID 1715994 DOI: 10.1098/Rspb.1991.0066 |
0.381 |
|
| 1990 |
Cerundolo V, Alexander J, Anderson K, Lamb C, Cresswell P, McMichael A, Gotch F, Townsend A. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature. 345: 449-52. PMID 2342577 DOI: 10.1038/345449A0 |
0.403 |
|
| 1990 |
Townsend A, Elliott T, Cerundolo V, Foster L, Barber B, Tse A. Assembly of MHC class I molecules analyzed in vitro. Cell. 62: 285-295. PMID 2196996 DOI: 10.1016/0092-8674(90)90366-M |
0.333 |
|
| 1989 |
Zanovello P, Cerundolo V, Bronte V, Giunta M, Panozzo M, Biasi G, Collavo D. Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity. Cellular Immunology. 122: 450-60. PMID 2788517 DOI: 10.1016/0008-8749(89)90091-9 |
0.773 |
|
| 1989 |
Zanovello P, Rosato A, Bronte V, Cerundolo V, Treves S, Di Virgilio F, Pozzan T, Biasi G, Collavo D. Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis. The Journal of Experimental Medicine. 170: 665-77. PMID 2769181 DOI: 10.1084/Jem.170.3.665 |
0.731 |
|
| 1987 |
Treves S, Di Virgilio F, Cerundolo V, Zanovello P, Collavo D, Pozzan T. Calcium and inositolphosphates in the activation of T cell-mediated cytotoxicity. The Journal of Experimental Medicine. 166: 33-42. PMID 3036996 DOI: 10.1084/Jem.166.1.33 |
0.744 |
|
| 1987 |
Cerundolo V, Lahaye T, Horvath C, Zanovello P, Collavo D, Engers HD. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone. European Journal of Immunology. 17: 173-8. PMID 3030766 DOI: 10.1002/Eji.1830170204 |
0.77 |
|
| 1987 |
Cerundolo V, Zanovello P, McIntosh D, Fabbris R, Davies AJ, Collavo D. Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes. British Journal of Cancer. 55: 413-9. PMID 2437947 DOI: 10.1038/Bjc.1987.81 |
0.77 |
|
| 1985 |
Zanovello P, Cerundolo V, Strada G, Fabbris R, Collavo D. Tumor therapy by adoptive transfer of ricin-treated cytotoxic T lymphocytes in mice International Journal of Immunopharmacology. 7: 406. DOI: 10.1016/0192-0561(85)90464-3 |
0.723 |
|
| 1985 |
Cerundolo V, Zanovello P, Giunta M, Fabbris R, Collavo D. In vitro transfer of ricin toxicity by tumor-specific cytotoxic T lymphocytes International Journal of Immunopharmacology. 7: 406. DOI: 10.1016/0192-0561(85)90463-1 |
0.738 |
|
| 1984 |
Collavo D, Ronchese F, Zanovello P, Cerundolo V, Biasi G. Reduction in precursors of cytotoxic T lymphocytes and of cells with natural killer-like activity in spleens of cyclophosphamide-treated mice. International Journal of Immunopharmacology. 6: 529-34. PMID 6334044 DOI: 10.1016/0192-0561(84)90092-4 |
0.774 |
|
| Show low-probability matches. |